Correlation Between Madrigal Pharmaceuticals and Cardiff Oncology
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Cardiff Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Cardiff Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Cardiff Oncology, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Cardiff Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Cardiff Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Cardiff Oncology.
Diversification Opportunities for Madrigal Pharmaceuticals and Cardiff Oncology
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Madrigal and Cardiff is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Cardiff Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiff Oncology and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Cardiff Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiff Oncology has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Cardiff Oncology go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Cardiff Oncology
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 2.71 times less return on investment than Cardiff Oncology. But when comparing it to its historical volatility, Madrigal Pharmaceuticals is 1.86 times less risky than Cardiff Oncology. It trades about 0.05 of its potential returns per unit of risk. Cardiff Oncology is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 149.00 in Cardiff Oncology on September 12, 2024 and sell it today you would earn a total of 229.00 from holding Cardiff Oncology or generate 153.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. Cardiff Oncology
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Cardiff Oncology |
Madrigal Pharmaceuticals and Cardiff Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Cardiff Oncology
The main advantage of trading using opposite Madrigal Pharmaceuticals and Cardiff Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Cardiff Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiff Oncology will offset losses from the drop in Cardiff Oncology's long position.| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
| Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. PDS Biotechnology Corp | Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. Eyenovia |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |